Real-World study tracks new epilepsy Drug's impact on stubborn seizures
NCT ID NCT06716801
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study follows 300 adults with focal epilepsy whose seizures are not well controlled by current medications. Researchers will track how many people have fewer seizures after adding cenobamate to their treatment over 6 to 12 months. The goal is to see how well the drug works in real-life settings across France, Germany, and Spain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital TARNIER COCHIN
RECRUITINGParis, France, France
Contact
Conditions
Explore the condition pages connected to this study.